Chapter 1 Flashcards
(32 cards)
______________ Occurs when the true effect of one drug are change with presence another drug or food or environmental chemical agent.
Drug Interaction
- not all drug interaction are ________
- It’s not just the drugs themselves that interact, it’s their ________ too.
- Many interactions are ______ related.
- Some interaction can be accommodated by using another member of the _________.
- bad
- metabolites
- dose
- same group
Mechanism of drug interaction:
- Pharmacokinetics Interaction
- Pharmacodynamic interaction:
_________ When the interaction can affect the process by which drug absorbed, distributed, metabolized, excreted (ADME)
Pharmacokinetics interaction
___________ When the effect of one drug changed by presence of another drug at its site of action.
Pharmacodynamic interaction
- Pharmacokinetics interaction:
A) Drug absorption interaction:
- example 1:
- Drug affected: penicillin.
- Interacting drug: Neomycin.
- Effect of interaction: Neomycin induce malabsorption stage.
- Type of interaction: pharmacokinetic antagonism at absorption stage.
- Pharmacokinetics interaction:
A) Drug absorption interaction:
- example 2:
- Drug affected: Tetracycline
- Interaction drug: Antacid containingCa2+ , Mg2+,milk, Fe2+
- Effect of interaction: Formation of poorly absorbed soluble chelate resulting in reduced antibiotic absorption.
- Type of interaction: pharmacokinetic antagonism at absorption stage.
- Pharmacokinetics interaction:
A) Drug absorption interaction:
- example 3:
- Drug affected: Quinolone antibiotic
- Interaction drug: Antacid containing Al3+ , Mg2+,milk, Fe2+
- Effect of interaction: Formation of poorly absorbed complex.
- Type of interaction: pharmacokinetic antagonism at absorption stage.
- Pharmacokinetics interaction:
B) Drug displacement (protein- binding) interaction:
- affect mainly the highly bound protein such as : sulfonamides, phenylbutazone.
- Type of interaction: pharmacokinetic synergism at displacement stage.
Why Drug displacement (protein- binding) is a good interaction?
Some drugs bind albumin and become inactive. High protein-affinity drugs like phenylbutazone displace them, increasing their free form and distribution.
_________ converting drug molecules into more polar compounds ( less active and water soluble ) to decrease reabsorption in the kidney and increase drug elimination.
metabolism
- Pharmacokinetics interaction:
C) Drug metabolism (biotransformation) interaction: ( Enzyme induction )
- Drug affect: corticosteroids, Theophylline
- Inducing agent: Barbiturate , Rifampin
- Effect of interaction: reduce effect
- Type of interaction: pharmacokinetic antagonism at metabolism stage
How inducing agent reduce affect of drug?
The inducing agent stimulates liver enzymes, so when the drug reaches the liver, its effect will be reduced.
- Pharmacokinetics interaction:
C) Drug metabolism (biotransformation) interaction: ( Enzyme inhibition )
- Drug affect: Anticoagulant
- Inducing agent: phenybutazone
- Effect of interaction: increase effect
- Type of interaction: pharmacokinetic synergism at metabolism stage
- Pharmacokinetics interaction:
C) Drug metabolism (biotransformation) interaction: ( Change in blood flow through the liver )
- Interaction drug: cimetidine.
- Effect of interaction: interaction drug decrease blood flow in the liver lead to decrease metabolism and first pass effect and increase bioavailability.
- Type of interaction: pharmacokinetic synergism at metabolic stage
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:
- Change in urinary pH
- Change in kidney blood flow
- Change in active kidney tubule excretion
- Biliary excretion and entero-hepatic shunt
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:- Change in urinary pH ( synergism acid )
- Affect drug: Acid
- Interacting agent: Acid (e.g: ammonium chloride)
- Effect of interaction: Decreases ionization → decreases excretion → increases effect
- Type on interaction: pharmacokinetic synergism at excretion stage
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:- Change in urinary pH ( antagonism acid )
- Affect drug: Acid
- Interacting agent: base (e.g: sodium bicarbonate)
- Effect of interaction: increase ionization → increase excretion → decreases effect
- Type on interaction: pharmacokinetic antagonism at excretion stage
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:- Change in urinary pH ( synergism base )
- Affect drug: bas
- Interacting agent: base (e.g: sodium bicarbonate )
- Effect of interaction: Decreases ionization → decreases excretion → increases effect
- Type on interaction: pharmacokinetic synergism at excretion stage
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:- Change in urinary pH ( antagonism base )
- Affect drug: base
- Interacting agent: acid (e.g: ammonium chloride)
- Effect of interaction: increase ionization → increase excretion → decreases effect
- Type on interaction: pharmacokinetic antagonism at excretion stage
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:- Change in kidney blood flow
- NSAID (non steroidal anti inflammatory drug) - e.g: phenylbutazone:
It decrease blood flow in Kidney and decrease excretion of another drug
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:- Change in active kidney tubule excretion
- Some drug compete the site of excretion of other drug at the kidney tubule.
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:- Change in active kidney tubule excretion:
- Effect drug: penicillin
- Interaction drug: probenecid
- Interaction effect: reduces active excretion of penicillin, allowing it to be passively reabsorbed by the kidneys.
- Type of interaction: pharmacokinetics antagonism at excretion stage
- Pharmacokinetics interaction:
D) Interaction due to change in excretion:- Biliary excretion and entero-hepatic shunt
- normal circulation (entro intestine hepatic circulation):
- Lipid soluble drug exerted in bile - metabolized by gut flora - return parent compound - reabsorb drug (this process elongate the drug action) - Abnormal circulation (entero hepatic shunt):
- antibiotic reduce the flora action - quick loss of drug.